Cardinal Health, Inc. $CAH Shares Bought by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 1,291,960.0% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 129,206 shares of the company’s stock after buying an additional 129,196 shares during the period. Manning & Napier Advisors LLC’s holdings in Cardinal Health were worth $27,303,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Aventura Private Wealth LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $25,000. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health during the 4th quarter worth $26,000. Bank of Jackson Hole Trust purchased a new stake in Cardinal Health during the 4th quarter worth about $27,000. Jones Financial Companies Lllp increased its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. Finally, Palladiem LLC acquired a new stake in Cardinal Health in the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE CAH traded up $1.77 during midday trading on Friday, hitting $235.54. 2,842,646 shares of the company’s stock were exchanged, compared to its average volume of 2,287,700. The firm’s fifty day simple moving average is $212.35 and its 200-day simple moving average is $212.99. The company has a market cap of $55.16 billion, a PE ratio of 36.01, a P/E/G ratio of 1.15 and a beta of 0.49. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $243.21.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 31.50%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CAH shares. TD Cowen lifted their price objective on Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a research note on Thursday. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday, May 1st. JPMorgan Chase & Co. lowered their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Wells Fargo & Company dropped their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Finally, Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $249.13.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.